PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20601342-3	2010	This variant show high frequency of p53 gene mutation and p53 over expression in comparison to the usual CCSK.	ccsk	105-109	tumor protein p53	Homo sapiens	36-39	
20601342-3	2010	This variant show high frequency of p53 gene mutation and p53 over expression in comparison to the usual CCSK.	ccsk	105-109	tumor protein p53	Homo sapiens	58-61	
12065773-12	2002	Our result indicates that p53 alterations are infrequent in CCSK and do not seem to be primary genetic events in the pathogenesis of CCSK.	ccsk	60-64	tumor protein p53	Homo sapiens	26-29	
12065773-2	2002	However, there are very few studies of p53 alterations in the other two rare and highly malignant renal tumors in childhood, in other words, clear cell sarcoma of the kidney (CCSK) and malignant rhabdoid tumor of the kidney (MRTK).	ccsk	175-179	tumor protein p53	Homo sapiens	39-42	
12007018-4	2002	We examined the status of p53 in CMN and CCSK in comparison to AWT by immunohistochemistry and mRNA analysis of p53, the downstream effector p21(WAF-1/CIP-1) ( p21), the multidrug resistance gene MDR-1, a putative target of p53, and the p53-antagonist Mdm-2.	ccsk	41-45	tumor protein p53	Homo sapiens	26-29